Targeted Pathologic Evaluation of Bone Marrow Donors Identifies Previously Undiagnosed Marrow Abnormalities

Por Tilson, MP, Jones, RJ, Sexauer, A, Griffin, CA, Morsberger, LA, Batista, DAS, Small, D, Burns, KH, Gocke, CD, Vuica-Ross, M, Borowitz, MJ, Duffield, AS
Publicado em 2013

A Pilot Study of Intensified PEG-Asparaginase in High Risk Acute Lymphoblastic Leukemia: Children’s Oncology Group Study AALL08P1

Por Rodriguez, V, Kairalla, J, Salzer, W, Raetz, E, Loh, ML, Carroll, A, Heerema, NA, Wood, B, Borowitz, MJ, Burke, MJ, Asselin, BL, Devidas, M, Winick, NW, Carroll, WL, Hunger, SP, Dreyer, ZE
Publicado no J Pediatr Hematol Oncol (2016)

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children’s Oncology Group Study AALL0031

Por Schultz, KR, Devidas, M, Bowman, WP, Aledo, A, Slayton, WB, Sather, H, Zheng, HW, Davies, SM, Gaynon, PS, Trigg, M, Rutledge, R, Jorstad, D, Carroll, AJ, Heerema, N, Winick, N, Borowitz, MJ, Hunger, SP, Carroll, WL, Camitta, B
Publicado no Leukemia (2014)

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children’s Oncology Group Study AALL0031

Por Schultz, KR, Carroll, A, Heerema, NA, Bowman, WP, Aledo, A, Slayton, WB, Sather, H, Devidas, M, Zheng, HW, Davies, SM, Gaynon, PS, Trigg, M, Rutledge, R, Jorstad, D, Winick, N, Borowitz, MJ, Hunger, SP, Carroll, WL, Camitta, B
Publicado no Leukemia (2014)